Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic trial on rocuronium in obese patients
2007-003005-27Phase 4Completed
- Sponsor
- Rigshospitalet Department of Anaesthesia, Centre of Head and Orthopaedics
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rocuronium in obesity and class III obesity, sponsored by Rigshospitalet Department of Anaesthesia, Centre of Head and Orthopaedics. Primary endpoint: Duration of action of rocuronium. Started Jun 2007; status: completed.
02
Drugs
rocuronium
03
Conditions
obesityclass III obesity
Beyond the preview
Go deeper on 2007-003005-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003005-27.